Does Undergoing a Prehabilitation Protocol Aimed at Optimizing Scapulothoracic Mobility and Strengthening Improve Internal Rotation After Reverse Shoulder Arthroplasty?
Recruiting now
Conditions studied: Primary Reverse Total Shoulder Arthroplasty
In brief
Difficulty with internal rotation (IR) after reverse shoulder arthroplasty (RSA) is common. Current rehabilitation protocols may not optimize IR. The investigator's objective is to assess the impact of prehabilitation focused on IR strengthening and mobility on RSA outcomes. The investigators will perform a prospective, randomized control trial to achieve the specific aim: assessing range of motion, strength, patient-reported outcomes, and activities of daily living requiring internal rotation between control and prehabilitation cohorts, with the prehabilitation patients receiving 6 weeks of treatment.
Key facts
- Study ID
- NCT07145957
- Run by
- University of Florida
- People needed
- 64
- Starts
- 2025-11-06
- Expected to finish
- 2028-09-01
- Last updated by the study team
- 2026-01-14
Who can join
Age: 40 and older, up to 80. Sex: any. Healthy volunteers: accepted.
You may not qualify if…
- Patients under the age of 40 and over the age of 80.
- Diagnosis of septic shoulder, fracture, or fracture sequelae, or tumor pathology of the ipsilateral shoulder
- Pre-existing hand, wrist, or elbow pathology that limits elbow flexion or extension, or forearm pronation or supination
- Planned to undergo synchronous procedure of the involved extremity (e.g., synchronous RSA and carpal tunnel release)
- Tendon transfer (e.g., Latissimus dorsi transfer) performed intraoperatively
- Patients without access to phone or email communication for at least 2 years after treatment
- Revision shoulder arthroplasty
Where it is running
- University of Florida Department of Orthopaedics and Rehabilitation — Gainesville, Florida, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.